{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T18:15:51Z","timestamp":1789841751860,"version":"4.0.1"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,1,11]],"date-time":"2021-01-11T00:00:00Z","timestamp":1610323200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001843","name":"Science and Engineering Research Board","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001843","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001407","name":"Department of Biotechnology, Ministry of Science and Technology, India","doi-asserted-by":"publisher","award":["BT\/PR27780\/MED\/29\/1266\/2018"],"award-info":[{"award-number":["BT\/PR27780\/MED\/29\/1266\/2018"]}],"id":[{"id":"10.13039\/501100001407","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1016\/j.biopha.2021.111275","type":"journal-article","created":{"date-parts":[[2021,1,20]],"date-time":"2021-01-20T06:04:41Z","timestamp":1611122681000},"page":"111275","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"special_numbering":"C","title":["Repurposing of existing therapeutics to combat drug-resistant malaria"],"prefix":"10.1016","volume":"136","author":[{"given":"Kanchan","family":"Yadav","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2078-7125","authenticated-orcid":false,"given":"Rahul","family":"Shivahare","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salique Hassan","family":"Shaham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prince","family":"Joshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anamika","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renu","family":"Tripathi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2021.111275_bib0005","series-title":"World Health Organization, World Malar. Rep.","year":"2019"},{"key":"10.1016\/j.biopha.2021.111275_bib0010","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.coph.2018.06.003","article-title":"Mechanisms of artemisinin resistance in Plasmodium falciparum malaria","volume":"42","author":"Suresh","year":"2018","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.biopha.2021.111275_bib0015","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1093\/infdis\/jiq024","article-title":"Methotrexate is highly potent against pyrimethamine-resistant Plasmodium vivax","volume":"203","author":"Imwong","year":"2011","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.biopha.2021.111275_bib0020","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1017\/S003118200500778X","article-title":"Blood schizontocidal activity of azithromycin and its combination with alpha\/beta arteether against multi-drug resistant Plasmodium yoelii nigeriensis, a novel MDR parasite model for antimalarial screening","volume":"131","author":"Tripathi","year":"2005","journal-title":"Parasitology"},{"key":"10.1016\/j.biopha.2021.111275_bib0025","doi-asserted-by":"crossref","first-page":"517","DOI":"10.4269\/ajtmh.2011.10-0285","article-title":"Doxycycline for malaria chemoprophylaxis and treatment: report from the CDC expert meeting on malaria chemoprophylaxis","volume":"84","author":"Tan","year":"2011","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.biopha.2021.111275_bib0030","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1016\/S0140-6736(18)32613-8","article-title":"Advancing the repurposing of ivermectin for malaria","volume":"393","author":"Chaccour","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.biopha.2021.111275_bib0035","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1158\/1078-0432.CCR-14-2034","article-title":"Idelalisib: first-in-class PI3K delta inhibitor for the treatment of chronic lymphocytic leukemia, small lymphocytic leukemia, and follicular lymphoma","volume":"21","author":"Yang","year":"2015","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.biopha.2021.111275_bib0040","doi-asserted-by":"crossref","first-page":"3732","DOI":"10.1016\/j.bmcl.2013.05.011","article-title":"Synthesis and biological evaluation of sorafenib- and regorafenib-like sEH inhibitors","volume":"23","author":"Hwang","year":"2013","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.biopha.2021.111275_bib0045","doi-asserted-by":"crossref","first-page":"2579","DOI":"10.1111\/febs.14097","article-title":"Oxidative stress in malaria and artemisinin combination therapy: pros and cons","volume":"284","author":"Kavishe","year":"2017","journal-title":"FEBS J."},{"key":"10.1016\/j.biopha.2021.111275_bib0050","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1016\/j.ejmech.2017.11.086","article-title":"Peptides having antimicrobial activity and their complexes with transition metal ions","volume":"143","author":"Je\u017cowska-Bojczuk","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.biopha.2021.111275_bib0055","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.jss.2014.01.063","article-title":"Progesterone augments epirubicin-induced apoptosis in HA22T\/VGH cells by increasing oxidative stress and upregulating Fas\/FasL","volume":"188","author":"Chang","year":"2014","journal-title":"J. Surg. Res."},{"key":"10.1016\/j.biopha.2021.111275_bib0060","doi-asserted-by":"crossref","first-page":"302","DOI":"10.3389\/fmicb.2016.00302","article-title":"Ambivalent outcomes of cell apoptosis: a barrier or blessing in malaria progression","volume":"7","author":"Kakani","year":"2016","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.biopha.2021.111275_bib0065","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2018.00907","article-title":"Tamoxifen-induced apoptosis of MCF-7 Cells via GPR30\/PI3K\/MAPKs interactions: verification by ODE modeling and RNA sequencing","volume":"9","author":"Rouhimoghadam","year":"2018","journal-title":"Front. Physiol."},{"key":"10.1016\/j.biopha.2021.111275_bib0070","doi-asserted-by":"crossref","first-page":"699","DOI":"10.3892\/ol.2014.2211","article-title":"5-Fluorouracil-induced apoptosis in colorectal cancer cells is caspase-9-dependent and mediated by activation of protein kinase C-\u03b4","volume":"8","author":"Mhaidat","year":"2014","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.biopha.2021.111275_bib0075","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1093\/femsre\/fuv046","article-title":"The immunological balance between host and parasite in malaria","volume":"40","author":"Deroost","year":"2016","journal-title":"FEMS Microbiol. Rev."},{"key":"10.1016\/j.biopha.2021.111275_bib0080","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1038\/ncomms2566","article-title":"Aldara activates TLR7-independent immune defence","volume":"4","author":"Walter","year":"2013","journal-title":"Nat. Commun."},{"key":"10.1016\/j.biopha.2021.111275_bib0085","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.actatropica.2015.06.024","article-title":"Leptin augments protective immune responses in murine macrophages and enhances potential of miltefosine against experimental visceral leishmaniasis","volume":"150","author":"Shivahare","year":"2015","journal-title":"Acta Trop."},{"key":"10.1016\/j.biopha.2021.111275_bib0090","doi-asserted-by":"crossref","first-page":"217","DOI":"10.2147\/JBM.S206459","article-title":"The immunomodulatory-drug, lenalidomide, sustains and enhances interferon-\u03b1 production by human plasmacytoid dendritic cells","volume":"10","author":"Kibata","year":"2019","journal-title":"J. Blood Med."},{"key":"10.1016\/j.biopha.2021.111275_bib0095","doi-asserted-by":"crossref","first-page":"3485","DOI":"10.1128\/AAC.00527-07","article-title":"Multiple antibiotics exert delayed effects against the Plasmodium falciparum apicoplast","volume":"51","author":"Dahl","year":"2007","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.biopha.2021.111275_bib0100","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1186\/s12936-015-0980-0","article-title":"Tetracyclines in malaria","volume":"14","author":"Gaillard","year":"2015","journal-title":"Malar. J."},{"key":"10.1016\/j.biopha.2021.111275_bib0105","doi-asserted-by":"crossref","first-page":"256","DOI":"10.3389\/fcimb.2018.00256","article-title":"Artemisinin derivatives and synthetic trioxane trigger apoptotic cell death in asexual stages of Plasmodium","volume":"8","author":"Gunjan","year":"2018","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.biopha.2021.111275_bib0110","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1128\/AAC.01607-06","article-title":"Assessment and continued validation of the malaria SYBR green I-based fluorescence assay for use in malaria drug screening","volume":"51","author":"Johnson","year":"2007","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.biopha.2021.111275_bib0115","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1002\/cbic.200390016","article-title":"Synthesis and biological evaluation of pyrazolylnaphthoquinones as new potential antiprotozoal and cytotoxic agents","volume":"4","author":"Sperandeo","year":"2003","journal-title":"Chembiochem"},{"key":"10.1016\/j.biopha.2021.111275_bib0120","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1016\/j.msec.2009.01.002","article-title":"Standardization of incubation conditions for hemolysis testing of biomaterials","volume":"29","author":"Henkelman","year":"2009","journal-title":"Mater. Sci. Eng. C"},{"key":"10.1016\/j.biopha.2021.111275_bib0125","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1017\/S0031182016000937","article-title":"Pyrrolidine-acridine hybrid in artemisinin-based combination: a pharmacodynamic study","volume":"143","author":"Pandey","year":"2016","journal-title":"Parasitology"},{"key":"10.1016\/j.biopha.2021.111275_bib0130","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.pt.2009.12.002","article-title":"Anticancer agents against malaria: time to revisit?","volume":"26","author":"Nzila","year":"2010","journal-title":"Trends Parasitol."},{"key":"10.1016\/j.biopha.2021.111275_bib0135","doi-asserted-by":"crossref","first-page":"2500","DOI":"10.1182\/blood-2009-08-238972","article-title":"PfPI3K, a phosphatidylinositol-3 kinase from Plasmodium falciparum, is exported to the host erythrocyte and is involved in hemoglobin trafficking","volume":"115","author":"Vaid","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.biopha.2021.111275_bib0140","article-title":"Computational chemogenomics drug repositioning strategy enables the discovery of epirubicin as a new repurposed hit for Plasmodium falciparum and P. vivax","volume":"64","author":"Ferreira","year":"2020","journal-title":"J. Exp. Ther. Oncol."},{"key":"10.1016\/j.biopha.2021.111275_bib0145","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1186\/s12936-019-3012-7","article-title":"Tamoxifen activity against Plasmodium in vitro and in mice","volume":"18","author":"Weinstock","year":"2019","journal-title":"Malar. J."},{"key":"10.1016\/j.biopha.2021.111275_bib0150","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/nrc1074","article-title":"5-fluorouracil: mechanisms of action and clinical strategies","volume":"3","author":"Longley","year":"2003","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.biopha.2021.111275_bib0155","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.molbiopara.2004.02.013","article-title":"Translational up-regulation of antifolate drug targets in the human malaria parasite Plasmodium falciparum upon challenge with inhibitors","volume":"136","author":"Nirmalan","year":"2004","journal-title":"Mol. Biochem. Parasitol."},{"key":"10.1016\/j.biopha.2021.111275_bib0160","doi-asserted-by":"crossref","DOI":"10.1038\/srep32575","article-title":"Skin scarification with Plasmodium falciparum peptide vaccine using synthetic TLR agonists as adjuvants elicits malaria sporozoite neutralizing immunity","volume":"6","author":"Mitchell","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.biopha.2021.111275_bib0165","doi-asserted-by":"crossref","first-page":"6050","DOI":"10.1038\/ncomms7050","article-title":"Dietary restriction protects against experimental cerebral malaria via leptin modulation and T-cell mTORC1 suppression","volume":"6","author":"Mejia","year":"2015","journal-title":"Nat. Commun."},{"key":"10.1016\/j.biopha.2021.111275_bib0170","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.pt.2009.09.001","article-title":"ABC - antibiotics-based combinations for the treatment of severe malaria?","volume":"25","author":"Noedl","year":"2009","journal-title":"Trends Parasitol."},{"key":"10.1016\/j.biopha.2021.111275_bib0175","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1186\/1475-2875-13-458","article-title":"Efficacy and safety of a combination of azithromycin and chloroquine for the treatment of uncomplicated Plasmodium falciparum malaria in two multi-country randomised clinical trials in African adults","volume":"13","author":"Sagara","year":"2014","journal-title":"Malar. J."},{"key":"10.1016\/j.biopha.2021.111275_bib0180","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1186\/1475-2875-13-339","article-title":"Recent progress in the development of anti-malarial quinolones","volume":"13","author":"Beteck","year":"2014","journal-title":"Malar. J."},{"key":"10.1016\/j.biopha.2021.111275_bib0185","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.actatropica.2006.10.008","article-title":"Activity of azithromycin or erythromycin in combination with antimalarial drugs against multidrug-resistant Plasmodium falciparum in vitro","volume":"100","author":"Nakornchai","year":"2006","journal-title":"Acta Trop."},{"key":"10.1016\/j.biopha.2021.111275_bib0190","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/s12915-015-0162-0","article-title":"Macrolides rapidly inhibit red blood cell invasion by the human malaria parasite, Plasmodium falciparum","volume":"13","author":"Wilson","year":"2015","journal-title":"BMC Biol."},{"key":"10.1016\/j.biopha.2021.111275_bib0195","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.exppara.2006.10.004","article-title":"Roxithromycin potentiates the effects of chloroquine and mefloquine on multidrug-resistant Plasmodium falciparum in vitro","volume":"115","author":"Min","year":"2007","journal-title":"Exp. Parasitol."},{"key":"10.1016\/j.biopha.2021.111275_bib0200","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/S0140-6736(84)90357-X","article-title":"Failure of chloroquine-erythromycin and chloroquine-tetracycline combinations in treatment of chloroquine-resistant falciparum malaria in eastern Thailand","volume":"1","author":"Phillips","year":"1984","journal-title":"Lancet"}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332221000603?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332221000603?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T12:07:32Z","timestamp":1760098052000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332221000603"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4]]},"references-count":40,"alternative-id":["S0753332221000603"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2021.111275","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2021,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Repurposing of existing therapeutics to combat drug-resistant malaria","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2021.111275","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"111275"}}